Innovent Biologics (HK:1801)
:1801
Want to see HK:1801 full AI Analyst Report?
Comparison Results
Innovent Biologics
HK$91.50
HK$138.02B
145.72
43.58%
14 Buy
0 Hold
0 Sell
Strong Buy
Akeso, Inc.
HK$151.00
HK$105.93B
-43.30
39.56%
10 Buy
2 Hold
0 Sell
Strong Buy
RemeGen Co. Ltd. Class H
HK$119.90
HK$65.25B
36.25
82.55%
8 Buy
0 Hold
0 Sell
Strong Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$27.54
HK$39.90B
-256.36
47.70%
3 Buy
0 Hold
0 Sell
Strong Buy
Shanghai Henlius Biotech, Inc. Class H
HK$84.45
HK$38.67B
―
75.46%
6 Buy
0 Hold
0 Sell
Strong Buy
Performance Comparison
HK:1801
Innovent Biologics
79.40
23.50
42.04%
HK:1530
3SBio
19.28
-1.40
-6.78%
HK:9926
Akeso, Inc.
115.00
27.10
30.83%
HK:9995
RemeGen Co. Ltd. Class H
85.80
38.90
82.94%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
23.16
6.22
36.72%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
71.15
27.65
63.56%